Acutus Medical, Inc. (NASDAQ: AFIB) reported Q2 EPS of ($0.60), $0.02 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $4.49 million.

For earnings history and earnings-related data on Acutus Medical, Inc. (AFIB) click here.